PMC5778721_01
18F-fluoride positron emission tomography/computed tomography bone scan - abnormalities found in the brain parenchyma
WJNM-17-65-g001.jpg
PMC5778721_01_WJNM-17-65-g001.jpg
F1
Figure 1 shows the abnormalities found in the brain parenchyma detected by the 18F-fluoride PET/CT bone scan, which are more subtle when compared with the somatostatin receptor imaging in Figure 2, using 68Ga DOTANOC PET/CT. Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.
68Ga DOTANOC positron emission tomography/computed tomography - abnormal uptake in brain parenchyma
WJNM-17-65-g002.jpg
PMC5778721_01_WJNM-17-65-g002.jpg
F2
Figure 1 shows the abnormalities found in the brain parenchyma detected by the 18F-fluoride PET/CT bone scan, which are more subtle when compared with the somatostatin receptor imaging in Figure 2, using 68Ga DOTANOC PET/CT. Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.
Magnetic resonance imaging confirming cerebral metastases
WJNM-17-65-g003.jpg
PMC5778721_01_WJNM-17-65-g003.jpg
F3
Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.